New Jersey Senate Bill S2759

New Jersey 2024-2025 Regular Session

• Introduced: 2/15/24
• Refer: 2/15/24

Caption

Requires health insurers, SHBP and SEHBP to provide coverage for diagnosis, evaluation and treatment of lymphedema.

Impact

If passed, this legislation would significantly impact the healthcare coverage landscape in New Jersey. By ensuring that patients suffering from lymphedema have access to necessary medical care, the bill aims to improve health outcomes and quality of life for affected individuals. The requirement for coverage extends to various types of insurance policies, including individual and group health benefits, thus aiming for universal access to treatment regardless of the insurance plan's nature. This move is predicated on the understanding that early treatment of lymphedema is crucial in managing the condition effectively.

Summary

Senate Bill S2759 was introduced to require health insurance providers in New Jersey to offer coverage for the diagnosis, evaluation, and treatment of lymphedema. This progressive and chronic condition stems from abnormalities in the lymphatic system that lead to fluid retention and swelling in the body's tissues. Under the provisions of this bill, health insurers, including those under the State Health Benefits Program and the School Employees' Health Benefits Program, will be mandated to cover medically necessary treatments as determined by healthcare professionals.

Contention

As with many healthcare-related legislative efforts, S2759 may face contention regarding the potential financial burden it could impose on insurance providers and the broader healthcare system. Opponents may argue that mandating coverage for additional medical conditions can lead to increased premiums for all insured individuals, raising questions about its economic feasibility. However, proponents highlight the long-term benefits of proactive treatment and the cost savings associated with preventing complications related to untreated lymphedema.